IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — GOGO

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.060.100.130.100.070.180.160.150.090.100.160.150.160.150.130.110.46
Short-term Investments----------------0.020.000.02------------
Accounts Receivable0.120.120.110.110.120.050.050.050.050.050.050.050.040.040.040.040.04
Inventory0.130.100.080.090.090.070.070.070.060.060.050.050.040.040.030.030.03
Total Current Assets0.410.430.420.390.350.350.340.340.290.260.340.290.300.270.240.190.53
Property, Plant & Equipment0.110.120.120.120.120.090.090.100.100.100.100.100.080.070.060.060.06
Goodwill0.190.190.190.190.190.000.000.000.000.000.000.000.000.000.000.000.00
Intangible Assets0.190.200.220.230.240.030.030.020.020.020.020.020.020.020.020.020.02
Total Non-current Assets0.830.850.870.880.880.460.460.470.480.490.420.440.420.410.200.160.16
Total Assets1.241.281.301.261.240.810.800.810.770.750.760.730.720.690.440.350.69
Accounts Payable0.100.080.070.060.070.030.030.020.020.020.010.020.020.020.010.010.01
Total Current Liabilities0.240.260.240.230.190.100.090.080.060.060.070.080.090.190.220.190.11
Long-term Debt0.810.810.830.830.830.580.590.590.590.590.690.710.710.820.820.821.18
Total Non-current Liabilities0.890.900.940.930.960.660.660.670.670.670.770.780.780.780.780.741.21
Total Liabilities1.121.161.191.161.160.760.750.750.730.740.850.860.870.971.000.931.32
Retained Earnings(1.18)(1.17)(1.18)(1.18)(1.19)(1.17)(1.18)(1.18)(1.23)(1.25)(1.34)(1.39)(1.41)(1.43)(1.67)(1.68)(1.61)
Total Stockholder Equity0.120.120.110.100.080.050.050.060.030.01(0.09)(0.13)(0.15)(0.28)(0.56)(0.58)(0.63)

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue222.81226.32230.56223.59226.04230.31137.80100.53102.06104.3297.8197.95103.2298.60108.16105.3297.8492.7592.3087.17
Cost of Revenue*--25.34----27.6829.33----------------------------
Gross Profit*--200.98----198.36200.98----------------------------
Research & Development9.706.5014.0015.7012.5013.9015.509.8010.309.2010.409.209.207.908.208.008.005.406.906.00
Selling, General & Admin23.9926.2130.7327.8628.6329.5263.6624.9221.8514.6516.5513.3413.2014.2013.9115.4715.3613.4614.1915.25
Total Operating Expenses*--165.79----162.40165.79----------------------------
Operating Income29.6531.6914.1928.7435.9635.19(24.15)19.0721.6834.6724.8833.3234.0531.9338.7036.3432.3434.9532.3330.91
Interest Expense17.5916.8517.5717.6816.4116.5612.249.678.118.418.258.037.818.989.438.789.7710.8910.9010.94
Pretax Income6.7721.03(8.59)(0.56)16.9818.99(36.40)12.150.9741.4119.1027.6426.0224.8430.7128.1622.7224.1321.4619.86
Tax Provision8.787.951.411.374.176.94(8.19)1.520.1310.924.646.73(63.83)4.393.047.980.701.94(187.67)0.13
Net Income(2.01)13.09(10.00)(1.93)12.8112.04(28.21)10.630.8430.4914.4720.9189.8520.4527.6720.1822.0222.20218.7110.96
Basic EPS(0.01)0.10(0.08)(0.01)0.100.09(0.22)0.080.010.240.110.160.690.160.210.160.180.202.110.10
Diluted EPS(0.01)0.10(0.08)(0.01)0.090.09(0.22)0.080.010.230.110.160.670.150.210.150.170.181.930.16

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow32.30(7.24)8.5046.8036.7132.47(38.32)25.1324.9529.66--18.6815.6318.5131.4727.7026.3717.8730.3426.75
Capital Expenditures9.5625.7233.9019.543.182.754.254.423.391.452.263.607.293.118.7317.719.887.601.431.55
Free Cash Flow*22.74(32.96)(25.40)27.2633.5329.72(42.57)20.7221.5628.21--15.088.3315.4022.749.9916.4910.2728.9125.21
Investing Cash Flow(10.62)(11.95)(16.45)(16.25)(4.79)(2.43)(333.98)(0.54)(0.08)(2.60)--(27.33)22.361.56------------
Financing Cash Flow(62.03)(2.61)(0.24)1.16(0.69)(1.57)237.59(9.45)(16.16)(13.30)--(2.41)(104.02)(7.44)------------

* Derived from reported values